Evidence map›Paper›PMID 41282344›Full record

ArticleFrontiers in cardiovascular medicine2025

Efficacy of left subclavian artery laser

Qi Zhang, Hao Zhao, Yongqiang Yue, Shuai Zhang, Likun Sun, Peng Xu, Chao Liu, Zhaohui Hua, Zhen Li

Abstract read
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Management of Left Subclavian Artery in Aortic Open and Endovascular Surgery.Journal of cardiovascular development and disease · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qi ZhangDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Hao ZhaoDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Yongqiang YueDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Shuai ZhangDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Likun SunDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Peng XuDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Chao LiuDepartment of Cardiovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhaohui HuaDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Zhen LiDepartment of Endovascular Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the early and mid-term outcomes of Methods: This retrospective study analyzed 57 patients (60+ years) treated from 2018 to 2023. LSA reconstruction-related complications were defined as: anastomotic bleeding, LSA occlusion, stent migration, or fenestration-related endoleak. Patients were divided into ISLF + debranching ( Results: The ISLF group had shorter operative time (323.1 ± 10.3 vs. 329.4 ± 7.2 min, Conclusion: ISLF with hybrid debranching improves LSA reconstruction success and reduces complications without affecting survival.

Indexed as

aortic dissectiondebranching hybrid surgerydissecting aneurysmin situ laser fenestrationleft subclavian arterythoracic aorta

Identifiers

PMID41282344
PMCPMC12631219

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.